Pro-Dex, a developer and manufacturer of technology-based solutions to medical, dental, semi-conductor, scientific research and aerospace markets, has appointed Harold Hurwitz as chief financial officer, effective 6 October 2010.
Hurwitz will succeed Jeffrey Ritchey who has left the company. Hurwitz began his career with Coopers & Lybrand, where he served for 22 years, leading its life science and high technology practices in Orange County.
From 1997 through 2004, Hurwitz was vice president and chief financial officer for Micro Therapeutics, a developer and manufacturer of interventional neurovascular medical devices.
Through February 2010, Hurwitz was vice president and chief financial officer for Interventional Spine, a medical device company focused on percutaneous systems for treatment of back pain.
Prior to that, he was a principal consultant with McDermott and Bull, a retained executive search firm where he specialised in serving the life science industry.
Pro-Dex chief executive officer Mark Murphy said that Hurwitz comes to the company with a broad financial background that includes Big 4 public accounting experience as a partner with Coopers & Lybrand, a part of PricewaterhouseCoopers, as well as public and private company financial management responsibility.